Griffin Asset Management, Inc. Abbott Laboratories Transaction History

Griffin Asset Management, Inc.

$879 Million
Q3 2024

A detailed history of Griffin Asset Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Griffin Asset Management, Inc. holds 65,035 shares of ABT stock, worth $7.63 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

65,035

Previous 65,383 0.53%

Holding current value

$7.63 Million

Previous $6.79 Million 9.14%

% of portfolio

0.84%

Previous 0.8%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$100.07 - $118.13 $34,824 - $41,109	-348 Reduced 0.53%	65,035 $7.41 Million
Q2 2024 Jul 23, 2024	BUY	$100.73 - $112.44 $43,817 - $48,911	435 Added 0.67%	65,383 $6.79 Million
Q1 2024 Apr 17, 2024	BUY	$109.52 - $120.96 $60,564 - $66,890	553 Added 0.86%	64,948 $7.38 Million
Q4 2023 Jan 19, 2024	BUY	$90.19 - $110.4 $5,140 - $6,292	57 Added 0.09%	64,395 $7.09 Million
Q3 2023 Oct 19, 2023	SELL	$95.53 - $114.62 $40,791 - $48,942	-427 Reduced 0.66%	64,338 $6.23 Million
Q2 2023 Aug 01, 2023	SELL	$100.78 - $112.29 $3,527 - $3,930	-35 Reduced 0.05%	64,765 $7.06 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $32,448 - $38,193	335 Added 0.52%	64,800 $6.56 Million
Q4 2022 Jan 20, 2023	SELL	$95.06 - $111.52 $1,425 - $1,672	-15 Reduced 0.02%	64,465 $0
Q3 2022 Oct 19, 2022	SELL	$96.76 - $112.03 $967 - $1,120	-10 Reduced 0.02%	64,480 $6.24 Million
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $63,793 - $77,106	-625 Reduced 0.96%	64,490 $7.01 Million
Q1 2022 Apr 12, 2022	SELL	$114.02 - $139.04 $119,721 - $145,992	-1,050 Reduced 1.59%	65,115 $7.71 Million
Q4 2021 Jan 28, 2022	BUY	$115.53 - $141.46 $28,882 - $35,365	250 Added 0.38%	66,165 $9.31 Million
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $74,079 - $81,953	-635 Reduced 0.95%	65,915 $7.79 Million
Q2 2021 Jul 28, 2021	SELL	$105.79 - $124.53 $103,674 - $122,039	-980 Reduced 1.45%	66,550 $7.72 Million
Q1 2021 May 04, 2021	SELL	$108.84 - $128.23 $177,082 - $208,630	-1,627 Reduced 2.35%	67,530 $8.09 Million
Q4 2020 Jan 27, 2021	SELL	$105.0 - $114.42 $80,640 - $87,874	-768 Reduced 1.1%	69,157 $7.57 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $2.15 Million - $2.61 Million	-23,413 Reduced 25.08%	69,925 $7.61 Million
Q2 2020 Aug 18, 2020	SELL	$76.57 - $98.0 $92,726 - $118,678	-1,211 Reduced 1.28%	93,338 $8.53 Million
Q1 2020 May 18, 2020	SELL	$62.82 - $91.86 $125,263 - $183,168	-1,994 Reduced 2.07%	94,549 $7.46 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $107,401 - $119,563	-1,368 Reduced 1.4%	96,543 $8.39 Million
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $655,211 - $710,452	-8,006 Reduced 7.56%	97,911 $8.19 Million
Q2 2019 Aug 19, 2019	SELL	$72.88 - $85.0 $126,811 - $147,900	-1,740 Reduced 1.62%	105,917 $8.91 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $1.03 Million - $1.24 Million	-15,488 Reduced 12.58%	107,657 $8.61 Million
Q4 2018 Mar 01, 2019	SELL	$65.56 - $74.27 $160,949 - $182,332	-2,455 Reduced 1.95%	123,145 $8.91 Million
Q3 2018 Nov 19, 2018	SELL	$60.81 - $73.36 $129,829 - $156,623	-2,135 Reduced 1.67%	125,600 $9.21 Million
Q2 2018 Aug 15, 2018	SELL	$57.57 - $63.54 $139,664 - $154,148	-2,426 Reduced 1.86%	127,735 $7.79 Million
Q1 2018 May 16, 2018	SELL	$56.27 - $63.62 $55,088 - $62,283	-979 Reduced 0.75%	130,161 $7.8 Million
Q4 2017 Feb 20, 2018	SELL	$53.68 - $57.47 $1.22 Million - $1.31 Million	-22,732 Reduced 14.77%	131,140 $7.48 Million
Q3 2017 Nov 15, 2017	SELL	$48.06 - $53.64 $347,377 - $387,709	-7,228 Reduced 4.49%	153,872 $8.21 Million
Q2 2017 Aug 29, 2017	BUY	N/A	161,100	161,100 $7.83 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffin Asset Management, Inc. with notifications on news.

Account

Griffin Asset Management, Inc. Abbott Laboratories Transaction History